Castleark Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-244,045
Closed -$14.3M 426
2017
Q2
$14.3M Buy
+244,045
New +$12.7M 0.47% 58

Other funds holding SYNH

Castleark Management's SYNH Position: Q3 2017 in Review

Castleark Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2017, closing a stake of 244,045 shares — an estimated $14.3M sold.

Castleark Management first reported a position in SYNH in Q2 2017 and held it in 1 quarter. The position peaked at $14.3M in Q2 2017. 238 funds tracked by Wall St. Rank hold SYNH as of Q3 2017.

  • Castleark Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2017 after selling out during the quarter.
  • Castleark Management sold 244,045 Syneos Health, Inc. Class A Common Stock shares in Q3 2017, an estimated $14.3M.
  • Castleark Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2017 and held it in 1 quarter.
  • Castleark Management's Syneos Health, Inc. Class A Common Stock position peaked at $14.3M in Q2 2017.
  • 238 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2017.

Based on Castleark Management's 13F filing for Q3 2017, filed 15 Nov 2017.